首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1575762

全球細胞擴增市場 - 2024-2031

Global Cell Expansion Market - 2024-2031

出版日期: 2024年10月22日 | 出版商:

DataM Intelligence | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

報告概述

全球電池擴張市場將於 2023 年達到 200 億美元，預計到 2031 年將達到 550 億美元，2024-2031 年預測期間複合年成長率為 15.3%。

細胞擴增是培養分離細胞多代的過程，以獲得患者再生反應所需的細胞數量。這涉及在封閉的培養容器中進行連續傳代以及使用培養基去除代謝物並提供營養。

此外，細胞擴增是生物技術和再生醫學中的關鍵過程，旨在增加用於治療應用的特定細胞類型的數量。它對於開發基於細胞的療法至關重要，例如幹細胞和免疫細胞，這些療法需要大量細胞。細胞擴增的意義在於生產用於癌症免疫治療、組織工程和再生醫學的功能性細胞。

市場動態：

驅動程式和限制

慢性病盛行率上升

由於癌症、糖尿病和自體免疫疾病等慢性疾病的增加，全球細胞擴增市場正在擴大。這導致了對再生醫學、細胞療法和個人化治療等先進療法的需求。細胞擴增對於開發這些治療方法至關重要，醫療保健提供者和研究人員正在尋求創新的解決方案，以滿足全球對有效治療方案的需求。

例如，根據健康指標與評估研究所的數據，到 2023 年，糖尿病將影響全球超過 5 億人，影響各年齡層的男性、女性和兒童。預計未來 30 年這一數字將加倍，達到 13 億，每個國家都會成長。全球盛行率為 6.1%，使糖尿病成為死亡和殘疾的十大原因之一。北非和中東的比率最高，為 9.3%，預計到 2050 年將升至 16.8%。

與細胞生物學相關的倫理問題

細胞生物學的倫理問題限制了細胞擴增市場。胚胎幹細胞的使用涉及破壞人類胚胎，因此在許多國家受到限制。成體幹細胞是一種符合道德的替代方案，通常涉及侵入性操作，引發了對患者同意和安全的擔憂。基因改造細胞對患者和環境構成潛在風險。這些道德問題正在阻礙細胞擴增市場的成長。

細分市場分析

全球細胞擴增市場根據產品類型、細胞類型、應用、最終用戶和地區進行細分。

此產品類型細分市場的儀器約佔細胞擴增市佔率的41.3%

產品類型細分市場的工具約佔41.3%。儀器對於細胞擴增至關重要，可以實現治療和研究目的的受控生長和增殖。自動化生物反應器、細胞計數器、離心機和培養箱在細胞培養過程中保持最佳條件，確保一致性、可擴展性和效率。這些設備對於再生醫學、免疫療法和組織工程至關重要。先進的儀器提高了細胞活力和產量，降低了污染風險，並生產出供臨床使用的高品質細胞。

例如，2024 年 9 月，10x Genomics, Inc. 推出了 Chromium Xo，這是一款新型單細胞儀器，專為在有限預算內尋求高品質資料的研究人員而設計。這種經濟實惠的常規高性能單細胞分析入口是其 Chromium 單細胞儀器系列的一部分。

市場地域佔有率

預計北美在整個預測期內將佔據總市場佔有率的 38.4% 左右

由於癌症發病率上升、政府資助增加、幹細胞療法研究以及對先進治療方法認知的提高，北美在整個預測期內預計將佔據約 38.4% 的總市場佔有率。

例如，2024 年 10 月，開發個人化（自體）細胞療法的私人生物技術公司 Aspen Neuroscience, Inc. 宣布擴大其位於托利松總部附近的聖地牙哥業務，新建一座 22,000 平方英尺的 GMP 生產設施誘導多能幹細胞（iPSC）衍生的細胞療法。

此外，2024 年 8 月，Pluri Inc 獲得了一項使用專有 3D 細胞擴增技術來擴增免疫細胞的新方法的美國專利。此技術模仿人體內免疫細胞的天然淋巴結樣環境，為細胞在規模和品質上高效擴張提供必要的條件。

Moreover, cell expansion is a crucial process in biotechnology and regenerative medicine, aiming to increase the quantity of specific cell types for therapeutic applications. It is essential for developing cell-based therapies, such as stem cells and immune cells, which require large numbers of cells. Cell expansion's significance lies in producing functional cells for cancer immunotherapy, tissue engineering, and regenerative medicine.

Market Dynamics: Drivers & Restraints

Rise in the prevalence of chronic diseases

The global cell expansion market is expanding due to the rise in chronic diseases like cancer, diabetes, and autoimmune disorders. This has led to a demand for advanced therapies like regenerative medicine, cell-based therapies, and personalized treatments. Cell expansion is crucial for developing these treatments, and healthcare providers and researchers are seeking innovative solutions to meet the global need for effective treatment options.

For instance, in 2023, according to Institute for Health Metrics and Evaluation, Diabetes affects over half a billion people globally, affecting men, women, and children of all ages. The number is projected to double to 1.3 billion in the next 30 years, with every country experiencing an increase. The global prevalence rate is 6.1%, making diabetes one of the top 10 leading causes of death and disability. North Africa and the Middle East have the highest rate at 9.3%, which is projected to rise to 16.8% by 2050.

Ethical concern related to cell biology

Ethical concerns in cell biology are limiting the cell expansion market. The use of embryonic stem cells, which involve human embryo destruction, has led to restrictions in many countries. Adult stem cells, an ethical alternative, often involve invasive procedures, raising concerns about patient consent and safety. Genetically modified cells pose potential risks to patients and the environment. These ethical concerns are hindering the growth of the cell expansion market.

Market Segment Analysis

The global cell expansion market is segmented based on product type, cell type, application, end user and region.

The instruments from the product type segment accounted for approximately 41.3% of the cell expansion market share

The instruments from the product type segment accounted for approximately 41.3%. Instruments are crucial in cell expansion, enabling controlled growth and multiplication for therapeutic and research purposes. Automated bioreactors, cell counters, centrifuges, and incubators maintain optimal conditions during cell culture, ensuring consistency, scalability, and efficiency. These devices are essential for regenerative medicine, immunotherapy, and tissue engineering. Advanced instrumentation improves cell viability and yield reduces contamination risks, and produces high-quality cells for clinical use.

For instance, in September 2024, 10x Genomics, Inc. launched Chromium Xo, a new single cell instrument designed for researchers seeking high-quality data on limited budgets. This affordable entry point into routine, high-performance single cell analysis is part of its fleet of Chromium single cell instruments.

Market Geographical Share

North America is estimated to hold about 38.4% of the total market share throughout the forecast period

North America is estimated to hold about 38.4% of the total market share throughout the forecast period due to rising cancer incidence, increased government funding, research on stem cell therapies, and increased awareness of advanced treatment methods.

For instance, in October 2024, Aspen Neuroscience, Inc., a private biotechnology company developing personalized (autologous) cell therapies, announced the expansion of its San Diego footprint near its headquarters in Torrey Pines, with a new 22,000 square foot facility for GMP manufacturing of induced pluripotent stem cell (iPSC)-derived cell therapies.

Moreover, in August 2024, Pluri Inc has been granted a US patent for a new method for expanding immune cells using proprietary 3D cell expansion technology. This technology mimics the natural lymph node-like environment of immune cells within the human body, providing cells with the necessary conditions for efficient expansion at scale and quality.

Market Segmentation

By Product Type

Automated Cell Expansion Systems

Instruments

Cell Expansion Supporting Equipment

Cell Counters

Flow Cytometers

Centrifuges

Other Supporting Equipment

Others

Consumables

Reagents

Media

Disposables

Tissue Culture Flasks

Others

Bioreactors

Microcarrier Bioreactors

Microcarrier-based anchorage-dependent bioreactors

Suspension-based anchorage-independent bioreactors

Perfusion/Hollow Fibre Bioreactors

By Cell Type

Animal Cells

Human Cells

Stem Cells (SCs)

Adult Stem Cells

Others

By Application

Regenerative Medicine and Stem Cell Research

Clinical Studies

Vaccine Production

Others

By End User

Biopharmaceutical & Biotechnology Companies

Research Institutes

Hospitals

Diagnostic Laboratories

Others

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

France

Italy

Spain

Rest of Europe

South America

Brazil

Argentina

Rest of South America

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Middle East and Africa

Competitive Landscape

The major global players in the market include Thermo Fisher Scientific, Inc, Merck KGaA, Becton, Dickinson and Company, GE Healthcare, Terumo BCT, Beckman Coulter Inc, Miltenyi Biotec, Stemcell Technologies, Inc., Takara Bio Inc., Lnza Group LTD among others.

Key Developments

In August 2024, HC Corporation Biomedical Division showcased a prototype of its new cell expansion system, LiCellGrow, at the ISCT Europe 2024 Regional Meeting in Gothenburg, Sweden. LiCellGrow allows pharmaceutical companies to visualize real-time metabolic changes in cells and automatically adjust cell culture conditions for optimal growth. It aims to increase the availability of cell and gene therapy products by accelerating the manufacturing of specific cells needed for these therapies.

In March 2024, Getinge has partnered with the bioprocessing company CellRev in the development of a continuous cell processing platform called Livit ACE (Adherent Cell Expansion). The solution is a breakthrough within allogenic cell therapy manufacturing.

Why Purchase the Report?

To visualize the global cell expansion market segmentation based on product type, cell type, application, end user and region as well as understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel data sheet with numerous data points of the cell expansion market level with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping available as excel consisting of key products of all the major players.

The global cell expansion market report would provide approximately 64 tables, 61 figures and 186 pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Cell Type
3.3. Snippet by Application
3.4. Snippet by End User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rise in the prevalence of chronic diseases
  - 4.1.1.2. Rise in the advancements of devices
- 4.1.2. Restraints
  - 4.1.2.1. Ethical concern related to cell biology
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Patent Analysis
5.6. PESTLE Analysis
5.7. SWOT Analysis
5.8. DMI Opinion

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Automated Cell Expansion Systems*
- 6.2.1. Introduction
6.3. Instruments
6.4. Consumables
6.5. Bioreactors

7. By Cell Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Type
7.2. Market Attractiveness Index, By Cell Type
7.3. Animal Cells*
- 7.3.1. Introduction
- 7.3.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.4. Human Cells
7.5. Stem Cells (SCs)
7.6. Adult Stem Cells
7.7. Others

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.2. Market Attractiveness Index, By Application
8.3. Regenerative Medicine and Stem Cell Research*
- 8.3.1. Introduction
- 8.3.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.4. Clinical Studies
8.5. Vaccine Production
8.6. Others

9. By End User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Biopharmaceutical & Biotechnology Companies*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Research Institutes
9.4. Hospitals
9.5. Diagnostic Laboratories
9.6. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Type
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.7.1. U.S.
  - 10.2.7.2. Canada
  - 10.2.7.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Type
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.7.1. Germany
  - 10.3.7.2. UK
  - 10.3.7.3. France
  - 10.3.7.4. Italy
  - 10.3.7.5. Spain
  - 10.3.7.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Type
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.7.1. Brazil
  - 10.4.7.2. Argentina
  - 10.4.7.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Type
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.7.1. China
  - 10.5.7.2. India
  - 10.5.7.3. Japan
  - 10.5.7.4. South Korea
  - 10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Type
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Thermo Fisher Scientific, Inc*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. Merck KGaA
12.3. Becton, Dickinson and Company
12.4. GE Healthcare
12.5. Terumo BCT
12.6. Beckman Coulter Inc
12.7. Miltenyi Biotec
12.8. Stemcell Technologies, Inc.
12.9. Takara Bio Inc.
12.10. Lnza Group LTD (*LIST NOT EXHAUSTIVE)